Liver International

The IASL at 50: past, present and future perspectives
pp. 1319-1324(6)

The prothrombin time-derived international normalized ratio: great for Warfarin, fair for prognosis and bad for liver-bleeding risk
pp. 1325-1327(3)
Authors: Caldwell, Stephen; Shah, Neeral

Noninvasive markers of liver fibrosis: playing the probabilities
pp. 1328-1331(4)
Author: Myers, Robert P.

Ribavirin mode of action in chronic hepatitis C: from clinical use back to molecular mechanisms
pp. 1332-1343(12)
Authors: Hofmann, Wolf Peter; Herrmann, Eva; Sarrazin, Christoph; Zeuzem, Stefan

Interlaboratory variability in assessment of the model of end-stage liver disease score
pp. 1344-1351(8)
Authors: Lisman, Ton; van Leeuwen, Yvonne; Adelmeijer, Jelle; Pereboom, Ilona T. A.; Haagsma, Elizabeth B.; van den Berg, Arie P.; Porte, Robert J.

Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C
pp. 1352-1362(11)
Authors: Calès, Paul; de Ledinghen, Victor; Halfon, Philippe; Bacq, Yannick; Leroy, Vincent; Boursier, Jérôme; Foucher, Juliette; Bourlière, Marc; de Muret, Anne; Sturm, Nathalie; Hunault, Gilles; Oberti, Frédéric

Disease progression and the risk factor analysis for chronic hepatitis C
pp. 1363-1369(7)
Authors: Sinn, Dong Hyun; Paik, Seung Woon; Kang, Pung; Kil, Jae Sook; Park, Sang Un; Lee, So-Young; Song, Soon Mi; Gwak, Geum-Youn; Choi, Moon Seok; Lee, Joon Hyoek; Koh, Kwang Cheol; Yoo, Byung Chul

Expression of multidrug resistance-associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin
pp. 1370-1380(11)
Authors: Vander Borght, Sara; Komuta, Mina; Libbrecht, Louis; Katoonizadeh, Aezam; Aerts, Raymond; Dymarkowski, Steven; Verslype, Chris; Nevens, Frederik; Roskams, Tania

Independent and opposite associations of trunk fat and leg fat with liver enzyme levels
pp. 1381-1388(8)
Authors: Perlemuter, Gabriel; Naveau, Sylvie; Belle-Croix, Frédéric; Buffet, Catherine; Agostini, Hélène; Laromiguière, Muriel; Cassard-Doulcier, Anne-Marie; Oppert, Jean-Michel

Prevalence and genotype distribution of hepatitis C virus among apparently healthy individuals in Mongolia: a population-based nationwide study
pp. 1389-1395(7)
Authors: Baatarkhuu, Oidov; Kim, Do Young; Ahn, Sang Hoon; Nymadawa, Pagvajav; Dahgwahdorj, Yagaanbuyant; Shagdarsuren, Manaljav; Park, Jun Yong; Choi, Jong Won; Oyunbileg, Janchiv; Oyunsuren, Tsendsuren; Han, Kwang Hyub

Increased flow-mediated vasodilation in cirrhotic patients with ascites: relationship with renal resistive index
pp. 1396-1401(6)
Authors: Cazzaniga, Massimo; Salerno, Francesco; Visentin, Stefania; Cirello, Ilaria; Donarini, Cesare; Cugno, Massimo

Hepatic granuloma: decreasing trend in a high-incidence area
pp. 1402-1407(6)
Authors: Sanai, Faisal M.; Ashraf, Suhail; Abdo, Ayman A.; Satti, Mohammed B.; Batwa, Faisal; Al-Husseini, Hussa; Saleh, Ahmed M.; Bzeizi, Khalid I.

Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis
pp. 1408-1416(9)
Authors: Fung, James; Lai, Ching-Lung; Fong, Daniel Yee-Tak; Yuen, John Chi-Hang; Wong, Danny Ka-Ho; Yuen, Man-Fung

An old disease makes a comeback
pp. 1417-1417(1)
Authors: Noto, Pasquale; Boumis, Evangelo; Passarelli, Francesca; Licci, Stefano

Induction of matrix metalloproteinase-1 gene transcription by tumour necrosis factor α via the p50/p50 homodimer of nuclear factor-κ B in activated human hepatic stellate cells
pp. 1418-1425(8)
Authors: Hozawa, Shigenari; Nakamura, Tetsuya; Nakano, Masaru; Adachi, Masayuki; Tanaka, Hirotoshi; Takahashi, Yoko; Tetsuya, Mine; Miyata, Naoteru; Soma, Hiromitsu; Hibi, Toshifumi

Resveratrol inhibits cell growth in a human cholangiocarcinoma cell line
pp. 1426-1436(11)
Authors: Roncoroni, Leda; Elli, Luca; Dolfini, Ersilia; Erba, Eugenio; Dogliotti, Elena; Terrani, Claudia; Doneda, Luisa; Grimoldi, Maria Grazia; Bardella, Maria Teresa

Origin of stellate cells from submesothelial cells in a developing human liver
pp. 1437-1445(9)
Authors: Loo, Christine K. C.; Wu, Xiao-Juan

RNA interference targeting the platelet-derived growth factor receptor β subunit ameliorates experimental hepatic fibrosis in rats
pp. 1446-1457(12)
Authors: Chen, Si-Wen; Zhang, Xing-Rong; Wang, Chong-Ze; Chen, Wei-Zhong; Xie, Wei-Fen; Chen, Yue-Xiang

Involvement of p38 mitogen-activated protein kinase pathway in honokiol-induced apoptosis in a human hepatoma cell line (hepG2)
pp. 1458-1464(7)
Authors: Deng, Junfang; Qian, Yigang; Geng, Lei; Chen, Jie; Wang, Xiaohui; Xie, Haiyang; Yan, Sheng; Jiang, Guoping; Zhou, Lin; Zheng, Shusen

Pathogenesis of Hepatitis E in pregnancy
pp. 1465-1465(1)
Authors: Renou, Christophe; Pariente, Alexandre; Nicand, Elisabeth; Pavio, Nicole

Pathogenesis of acute hepatitis E virus infection in pregnancy
pp. 1466-1466(1)
Authors: Navaneethan, Udayakumar; Al Mohajer, Mayar; Shata, Mohamed T.

Possible association of autoimmune hepatitis and splenic artery aneurysms
pp. 1467-1468(2)
Authors: Shelton, Edward; Dowling, Richard; Taggart, Gregory; Nicoll, Amanda J.